Clinical Trials Logo

Clinical Trial Summary

T2DM, a chronic progressive disorder has an epidemic status in India. Remission (HbA1c of < 6.5% without any anti-diabetic medication) of T2DM is achievable with diet modifications in recently diagnosed obese T2D individuals. Studies suggest Very Low Calorie Diet (600 - 800kcal) and Low Calorie Diet-LCD (800 -1000 kcal) using Meal replacers (MR) are helpful. The investigators aimed to study the effects of LCD without any anti diabetic medication in intervention group and later comparing it with Control group (on standard medical treatment).


Clinical Trial Description

The objective is to study the effect of LCD in anthropometric , biochemical and NAFLD (Non Alcholic Fatty Liver Disease) parameters after 8 weeks and 24 weeks from enrollment.

Purposive sampling is used to enroll participants in the study. The LCD is a combination of one meal replacer and modified major meals. Calculated exchanges of food groups is taken care of in the other two major meals and snacks in between. Inorder to adhere compliance clinical (at baseline, after 8 weeks, after 24 weeks) as well as virtual visits through whatsapp, e-mails, SMS, phone calls (once a week during 8 weeks of intervention and further once a month upto 24 weeks) are scheduled. After 8 weeks of LCD, calorie is increased to 1200-1400 Kcal/day. In the control group the standard medical treatment is continued.

The data is collected in case report form and analysed using SPSS software by statistician. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04363710
Study type Interventional
Source Max Healthcare Insititute Limited
Contact
Status Completed
Phase N/A
Start date May 31, 2017
Completion date November 7, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05606471 - Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets Phase 4
Completed NCT05072990 - Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
Withdrawn NCT02977039 - Effect of a Plant Rich Diet on in People With Type 2 Diabetes and Obesity N/A
Recruiting NCT06223490 - Effect of Cryolipolysis on Insulin Resistance N/A
Recruiting NCT05277558 - Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Recruiting NCT04621929 - Obesity and Uric Acid Stones Study Phase 3
Completed NCT04332354 - Glycemic Profile by CGMS in Diabetic Patients After Bariatric Surgery
Completed NCT05890950 - A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes Phase 1
Withdrawn NCT04910997 - Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes N/A
Recruiting NCT04931836 - The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults N/A
Recruiting NCT06005012 - Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM Phase 2
Terminated NCT04741074 - Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy Phase 3
Recruiting NCT05838287 - Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants Phase 4
Active, not recruiting NCT04916314 - REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes N/A
Completed NCT04303819 - The Effect of Exenatide on Fasting Bile Acids
Recruiting NCT05446415 - L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP N/A
Recruiting NCT05770076 - Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study) N/A
Active, not recruiting NCT05409027 - A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62 Phase 1
Completed NCT02937987 - Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic Patients